These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25482252)

  • 1. Atrial fibrillation and stroke - Coexistence and attitude to preventive therapy on the basis of Szczecin and Szczecin region patients.
    Gołąb-Janowska M; Meller A; Kotlęga D; Bajer-Czajkowska A; Nowacki P
    Neurol Neurochir Pol; 2014; 48(6):410-5. PubMed ID: 25482252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with undertreatment of atrial fibrillation in geriatric outpatients with Alzheimer disease.
    Tavassoli N; Perrin A; Bérard E; Gillette S; Vellas B; Rolland Y;
    Am J Cardiovasc Drugs; 2013 Dec; 13(6):425-33. PubMed ID: 23943094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
    Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The atrial fibrillation in Turkey: Epidemiologic Registry (AFTER).
    Ertas F; Eren NK; Kaya H; Aribas A; Acar G; Kanadasi M; Gedik S; Oylumlu M; Yuksel M; Ulgen MS;
    Cardiol J; 2013; 20(4):447-52. PubMed ID: 23677730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study.
    Naganuma M; Shiga T; Sato K; Murasaki K; Hashiguchi M; Mochizuki M; Hagiwara N
    Thromb Res; 2012 Jul; 130(1):21-6. PubMed ID: 22137743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
    Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticoagulant treatment in patients with atrial fibrillation, according to risk factors for stroke].
    Lamy C; Mas JL
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):23-33. PubMed ID: 24463061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial Fibrillation in Transient Ischemic Attack Versus Ischemic Stroke: A Swedish Stroke Register (Riksstroke) Study.
    Buchwald F; Norrving B; Petersson J
    Stroke; 2016 Oct; 47(10):2456-61. PubMed ID: 27561674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrial fibrillation and stroke].
    Mattle HP; Schwerzmann M; Seiler Ch
    Ther Umsch; 2003 Sep; 60(9):527-34. PubMed ID: 14579621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients.
    Rizos T; Wagner A; Jenetzky E; Ringleb PA; Becker R; Hacke W; Veltkamp R
    Cerebrovasc Dis; 2011; 32(3):276-82. PubMed ID: 21893980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006.
    Béjot Y; Ben Salem D; Osseby GV; Couvreur G; Durier J; Marie C; Cottin Y; Moreau T; Giroud M
    Neurology; 2009 Jan; 72(4):346-53. PubMed ID: 19171832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral anticoagulant use in patients with atrial fibrillation].
    Ertaş F; Duygu H; Acet H; Eren NK; Nazli C; Ergene AO
    Turk Kardiyol Dern Ars; 2009 Apr; 37(3):161-7. PubMed ID: 19553738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of atrial fibrillation in Turkey: preliminary results of the multicenter AFTER study.
    Ertaş F; Kaya H; Kaya Z; Bulur S; Köse N; Gül M; Kahya Eren N; Cağlıyan CE; Köroğlu B; Vatan B; Acar G; Yüksel M; Bilik MZ; Gedik S; Simşek Z; Akıl MA; Yılmaz R; Oylumlu M; Arıbaş A; Yıldız A; Aydın M; Yeter E; Kanadaşı M; Ergene O; Ozhan H; Ulgen MS
    Turk Kardiyol Dern Ars; 2013 Mar; 41(2):99-104. PubMed ID: 23666295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient atrial fibrillation and risk of stroke after acute myocardial infarction.
    Bishara R; Telman G; Bahouth F; Lessick J; Aronson D
    Thromb Haemost; 2011 Nov; 106(5):877-84. PubMed ID: 21866303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.